Cargando…
Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good
• Expert evaluations of the safety, efficacy and cost-effectiveness of pharmaceutical and medical devices, prior to marketing approval or reimbursement listing, collectively represent a globally important public good. The scientific processes involved play a major role in protecting the public from...
Autor principal: | Faunce, Thomas Alured |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513209/ https://www.ncbi.nlm.nih.gov/pubmed/16569240 http://dx.doi.org/10.1186/1744-8603-2-5 |
Ejemplares similares
-
Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender Treaty
por: Faunce, Thomas Alured, et al.
Publicado: (2008) -
Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal
por: Faunce, Thomas A
Publicado: (2007) -
'Linkage' pharmaceutical evergreening in Canada and Australia
por: Faunce, Thomas A, et al.
Publicado: (2007) -
Why the MDGs need good governance in pharmaceutical systems to promote global health
por: Kohler, Jillian Clare, et al.
Publicado: (2014) -
Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health
por: Mackey, Tim K, et al.
Publicado: (2013)